Int J Clin Pract. 2020 Nov 26:e13861. doi: 10.1111/ijcp.13861. Online ahead of print.
ABSTRACT
BACKGROUND: We studied whether significant differences in care gaps exist between specialists and PCPs.
METHODS: GOAL Canada enrolled patients with CVD or familial hypercholesterolemia (FH) and LDL-C > 2.0 mmol/L despite maximally tolerated statin therapy. During follow-up, physicians received online reminders of treatment recommendations based on Canadian Guidelines.
RESULTS: A total of 177 physicians (58% PCPs) enrolled 2009 patients; approximately half of the patients were enrolled by each physician group. Patients enrolled by specialists were slightly older (mean age 63 years vs. 62), female (45% vs. 40%), Caucasian (77% vs. 65%), and had a slightly higher systolic pressure and lower heart rate. Patients enrolled by specialists had less frequent history of familial hypercholesterolemia, diabetes, hypertension, chronic kidney disease and liver disease but more frequent history of coronary artery disease, atrial fibrillation and premature family history of CVD. There was no significant baseline difference in LDL-C, HDL-C, or non-HDL-c, although total cholesterol and triglycerides were slightly higher in patients managed by PCPs. At baseline, PCPs were more likely to use statins (80% vs.73%, p=0.0002) and other therapies such as niacin or fibrate (10% vs. 6%, p=0.0006) but similar use of ezetimibe (24% vs. 27%, p=0.15). At the end of follow up, specialists used less statins (70% vs. 77%, p=0.0005) and other therapies (6% vs. 10%, p=0.007) but more ezetimibe (45% vs. 38%, p=0.01) and the same frequency of PCSK9i (28% vs. 27%, p=0.65). The proportion of patients achieving the recommended LDL-C level of 2.0 mmol/L or below (primary endpoint) was similar at last available visit between specialists and PCPs (44% vs. 42%, p=0.32).
CONCLUSION: Despite minor differences in the clinical profile of their patients, both PCPs and specialists actively participate in the management of lipid lowering therapy in high risk CVD patients and experience similar challenges and care gaps.
PMID:33244861 | DOI:10.1111/ijcp.13861
"between" - Google News
November 27, 2020 at 01:00PM
https://ift.tt/3fFL5Yp
Does Management of Lipid Lowering Differ Between Specialists and Primary Care: Insights from GOAL Canada - DocWire News
"between" - Google News
https://ift.tt/2WkNqP8
https://ift.tt/2WkjZfX
Bagikan Berita Ini
0 Response to "Does Management of Lipid Lowering Differ Between Specialists and Primary Care: Insights from GOAL Canada - DocWire News"
Post a Comment